Antibody Drug Conjugates (ADCs)
HAS Group offers fully integrated ADC development and manufacturing services, providing a true one-stop-shop solution for biopharma companies. From payload synthesis and monoclonal antibody production to bioconjugation and commercial supply, our capabilities cover the entire ADC value chain, helping clients accelerate timelines, streamline technology transfer, and ensure the highest quality standards throughout development and manufacturing.
